Home › Funds › Citigroup Inc › BVS

Citigroup Inc position in BVS

BIOVENTUS INC · Health Care

Latest position (Q2 2026)38.67K sh
Reported value held$365.03K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q3 2021 19.52K $276.00K New
Q4 2021 18.19K $264.00K Reduce
Q1 2022 17.39K $245.00K Reduce
Q2 2022 19.15K $131.00K Add
Q3 2022 17.82K $125.00K Reduce
Q4 2022 982 $2.56K Reduce
Q1 2023 71 $76 Reduce
Q2 2023 387 $1.12K Add
Q3 2023 52.53K $173.36K Add
Q4 2023 124.52K $656.24K Add
Q1 2024 129.86K $675.27K Add
Q2 2024 8.52K $49.00K Reduce
Q3 2024 27.45K $327.97K Add
Q4 2024 31.97K $335.71K Add
Q1 2025 29.02K $265.54K Reduce
Q2 2025 18.72K $123.95K Reduce
Q3 2025 3.96K $26.51K Reduce
Q4 2025 2.27K $16.88K Reduce
Q1 2026 2.44K $22.32K Add
Q2 2026 38.67K $365.03K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding BVS

All BVS fund holders →